Skip to Main Content

Paper Details

Reply to J.J. Tao et al.
J Clin Oncol
1
2018
Author NameAffiliation
Funda Meric-BernstamSarah Cannon Research Institute Tennessee Oncology, The University of Texas MD Anderson Cancer Center, Francis Crick Institute, Duke University Medical Center, Sarah Cannon Research Institute and Tennessee Oncology, Dana-Farber Cancer Institute Harvard Medical School, Washington University School of Medicine, Moores Cancer Center, University of California
Charles SwantonSarah Cannon Research Institute Tennessee Oncology, The University of Texas MD Anderson Cancer Center, Francis Crick Institute, Duke University Medical Center, Sarah Cannon Research Institute and Tennessee Oncology, Dana-Farber Cancer Institute Harvard Medical School, Washington University School of Medicine, Moores Cancer Center, University of California
Ron BoseSarah Cannon Research Institute Tennessee Oncology, The University of Texas MD Anderson Cancer Center, Francis Crick Institute, Duke University Medical Center, Sarah Cannon Research Institute and Tennessee Oncology, Dana-Farber Cancer Institute Harvard Medical School, Washington University School of Medicine, Moores Cancer Center, University of California
Mary S BeattieSarah Cannon Research Institute Tennessee Oncology, The University of Texas MD Anderson Cancer Center, Francis Crick Institute, Duke University Medical Center, Sarah Cannon Research Institute and Tennessee Oncology, Dana-Farber Cancer Institute Harvard Medical School, Washington University School of Medicine, Moores Cancer Center, University of California
  • 1 - 4

Datasets